Some assays cannot remain frozen in time when the target they detect is changing.
Using hantavirus as an example, Jesse Young, Ph.D., asks how oversight should account for tests that must evolve to keep serving a regional population.
#LDT #IVD #Diagnostics
1
107
Watch the full episode on Spotify: open.spotify.com/episode/0Yg…
Watch the full episode on YouTube: youtu.be/GFTDf-I1Vw0?si=VhwP…
3
In this Expert Insights article, DCN Dx COO Dr. Pat Vaughan breaks down the semi-quantitative #LFA format: cut-off engineering, reader selection, and the design decisions that determine whether semi-quantitative is the right call for your program. Link in comments.
#LateralFlow
1
10
Who counts as a "naive operator" in a #CLIA waiver study is more specific than teams assume. Emily Friedland (VP, #ClinicalResearch) and Dan Simpson (Director, #RegulatoryAffairs) explain how to design the comparison study for a molecular diagnostic. Link in comments. #IVD
1
16
Read here: dcndx.com/insights/designing…
Missed Part 1? Start here: dcndx.com/insights/clia-waiv…
6
Developing or validating a molecular diagnostic assay? Meet DCN Dx at #AMP2026 in Seattle, Nov. 12–14. Find us at booth 1031 to discuss clinical research, regulatory affairs, and #biospecimens.
#MolecularDiagnostics #IVD #CRO
Listen on Spotify or your favorite podcast platform: open.spotify.com/episode/3cL…
8
Developing or validating a molecular diagnostic assay? Meet DCN Dx at #AMP2026 in Seattle, Nov. 12–14. Find us at booth 1031 to discuss clinical research, regulatory affairs, and #biospecimens.
#MolecularDiagnostics
The #miniDxR is a customizable #lateralflow reader designed for point-of-care settings, combining quantitative readout accuracy with a form factor practical for both development environments and clinical deployment.
Learn more: hubs.ly/Q04DMmgT0
#PointOfCare #IVD
17
Listen on Spotify or your favorite podcast platform: open.spotify.com/episode/3cL…
4
Developing or validating a molecular diagnostic assay? Meet DCN Dx at #AMP2026 in Seattle, Nov. 12–14. Find us at booth 1031 to discuss clinical research, regulatory affairs, and #biospecimens.
#MolecularDiagnostics
The next respiratory wave will not wait for your study team to finish planning.
Listen to Expert Insights this weekend. Next week, ask: Is our CRO selected, are the right sites engaged, and are we ready to enroll?
Link 👇
#IVD #ClinicalTrials #RespiratoryDiagnostics #CRO
1
19
Developing or validating a molecular diagnostic assay? Meet DCN Dx at #AMP2026 in Seattle, Nov. 12–14. Find us at booth 1031 to discuss clinical research, regulatory affairs, and #biospecimens.
#MolecularDiagnostics










